Immune Modulation, Inc. (IMI) has discovered a life-saving, plant-based drug that combats some of the most endemic diseases plaguing the world. IMI has discovered and pioneered the development of a revolutionary pharmaceutical agent that has anti-malarial, anti-inflammatory, anti-viral, and anti-parasitic properties. IMI is a biomedical start-up comprised of a diverse set of accomplished Research Scientists and Medical Practitioners—inspired by the incredible power of natural medicine, and driven by our own unique capability to harness it. Our mission is to address global, unmet medical needs through the development of novel pharmaceutical, nutraceutical, and cosmetic agents from natural bio-resources that treat and prevent a variety of human diseases. Here at IMI, we are Researchers, we are Practitioners, but most importantly, we are Citizens of Humanity looking to bring breakthrough medicine to the masses. We are uniquely poised to radically alter the global healthcare landscape by delivering orally bio-available, more effective, and non-toxic therapeutics.